The regional binding of the opiate receptor ligand diprenorphine has been examined in rat brain both in vivo and in vitro. The time course of total label in specific brain regions was followed up to 2 h after intra venous bolus injection of [ 3 H]diprenorphine, with or without a pulse chase of unlabelled diprenorphine at 30 min. In addition, total label was measured 30 min after injection of labelled diprenorphine at nontracer concen trations over a range of specific activities. Total data sets for each region were fitted simultaneously to a compart mental model to give estimates of maximal binding ca pacity (Bmax) , the second-order apparent association rate constant, and the first-order dissociation rate constant of the receptor-ligand complex. The model incorporated the use of a reference region with low specific binding (cer ebellum). The binding of diprenorphine to rat brain ho mogenates was measured in vitro under equilibrium con ditions at 37°C, pH 7. 4, in the presence and absence of Diprenorphine binds to f,L-0-, and K-opiate recep tor subtypes with similar affinities for each in vivo (Iwamoto and Martin, 1981; Richards and SaMe, 1985). Previous studies using [11C]diprenorphine and positron emission tomography (PET) suggest that it is a promising tracer for quantitation of re gional opioid receptor binding in humans (Jones et aI., 1988; Frost et ai., 1989a,b). The purpose of the present study in the rat was to examine the relation ship between regional estimates of binding param eters derived from compartmental analysis of dy-
1 naloxone, to give corresponding regional estimates of Bmax and the half-saturation constant Kd• The results showed a close correlation between in vitro and in vivo regional estimates of Bmax over a wide range. There were no significant interregional differences either in Kd in vitro or in the Kd derived from the in vivo analysis, al though in vitro and in vivo estimates differed by an order of magnitude. This work was carried out as part of a validation study with a view to the application of the com partmental model to data ohtained in vivo in humans us ing positron emission tomog; dphy, when successive stud ies over a range of specific activities are not feasible. Restriction of the rat data to tracer alone and pulse chase protocols showed that the compartmental model gave re gional estimates of the combined forward rate constant consistent with estimates obtained using the complete data set. Key Words: Compartmental model-Dipre norphine-Opiate receptors.
namic tracer data in vivo and direct regional mea sures carried out under equilibrium conditions in vitro. The compartmental analysis involves the use of a reference region displaying low specific binding relative to the region of interest (ROI).
METHODS

Animals
Male Sprague-Dawley rats (Halan Olac Ltd., Bicester) weighing 250-280 g were used for all procedures. They were housed on a 12-h light-dark cycle with food and water ad libitum. For experiments in vivo, a tail artery and vein were cannulated with polythene tubing (ID 0. 58 mm, OD 0. 96 mm; Portex Ltd., Kent) for blood sampling and intravenous administration of radioligand, respec tively. Cannulation was carried out under isoflurane an aesthesia with N20 plus O2, The animals were then al lowed to recover for 2-3 h under light restraint prior to the experiments, which were all initiated between 1300 and 1400 h.
Chemicals
[15,16(N)-3 H)Diprenorphine (1.147-1.284 GBq/�mol) was purchased from Amersham International. Naloxone chlorhydrate was obtained from Dupont and diprenor phine was kindly donated by Reckitt & Coleman.
Binding assay in vitro
The in vitro binding assay is based on that of Geary and Wooten (1983) except that it was carried out at 37°C. Rats were decapitated, the brain was removed, and ROIs (thal amus, anterior cortex, posterior cortex, caudate-puta men, hippocampus, brainstem plus medulla, and cervical spinal cord) were dissected on ice. For each experiment, tissue was pooled from two rats and � 250 mg of each region was homogenised for 10 s in ice-cold phosphate buffered saline at pH 7. 4 (75 mUg, vol/wt), using an Ultra Turrex homogeniser at setting 0. 5. Aliquots of the ho mogenates were taken for assay of binding (below) and for assay of protein (Lowry et aI. , 1951) .
Binding assay incubations (I ml) contained 3. 33 mg wet wt tissue (�300 �g protein) and [ 3 H)diprenorphine in a range of concentrations (0. 1, 0.2, 0. 4, 0. 6, 0. 8, 1. 0, 5. 0, and 10. 0 nM) with or without naloxone (20 ILM) in buffer. Incubation was at 37°C for 25 min and was terminated by rapid filtration through Whatman GF/B filters in a Bran del Cell Harvester, followed by two rapid washes of the filtrate with 5 ml ice-cold buffer. Filters were left over night in 4 ml scintillant (Hionic-Fluor; Packard) and counted using a Beckman LS 6800. Within each experi ment, triplicate measures were carried out at each con centration of diprenorphine and naloxone. The experi ments for each region were repeated four times.
Binding isotherms were analysed in terms of the equa tions Btot = Bmax . F/(Kd + F) + Kns . F (in the absence of naloxone) and Btot = Kns . F (in the presence of nal oxone), where Btot (pmol/g wet wt) is the observed bound diprenorphine in the presence or absence of naloxone and F (nM) is the free concentration of diprenorphine (original total concentration with correction for observed bound fraction).
Estimates of the parameters Bmax (maximal binding ca pacity; pmol/g wet wt), Kd (equilibrium dissociation con stant; nM), and Kns (nonspecific binding constant; ml/g wet wt) were obtained from simultaneous, nonlinear, least-mean-squares fits of the data, with and without nal oxone, to the above equations, using a Simplex algorithm (Neider and Mead, 1965) with all data points being given equal weight.
Distribution of label in brain in vivo
The distribution of label in brain following intravenous bolus administration of [ 3 H)diprenorphine was measured in three experimental protocols; tracer alone, pulse chase, and varying specific radioactivity.
In the tracer alone protocol, rats received � 370 kBq of tracer in 200 ILl Na citrate/acetate buffer (pH 7.4) at zero time and were killed at specified times up to 120 min after injection. In the pulse chase protocol, rats received the same dose of [ 3 H)diprenorphine at zero time, a further intravenous bolus injection of unlabelled diprenorphine (470 pmol/g body wt) at 30 min, and were killed at times up to 90 min. In the varying specific radioactivity proto col, the zero time injectate also contained additional un labelled diprenorphine at six concentrations such that the total dose of diprenorphine ranged from 8 to 1,154 pmol/g body wt. These rats were killed at 30 min. In all studies, up to five blood samples (200 ILl each) were withdrawn from each rat at various times up to death and aliquots of blood and plasma taken for radioactive counting.
Rats were killed by intravenous injection of Expiral (Ceva Ltd., Watford), the brains were rapidly removed, and ROIs were dissected as described for the in vitro experiments. Samples of brain tissue from individual rats were weighed, solubilised in Soluene-350 (Packard, Gro ningen; 0. 5 ml), and assayed for radioactivity in scintillant (10 ml) containing I % acetic acid to suppress chemilumi nescence.
All data were normalised for precise dose and body weight before further calculation and for presentation purposes are expressed as units of uptake, defined as: (dpm per gram wet weight tissue)/(dpm injected per gram body weight).
Kinetic analyses
Compartmental analyses of the time course of labelled diprenorphine in brain regions in vivo were based on the model illustrated in Fig. I . The model is derived from those summarised by Huang et al. (1986) modification of the reference tissue approach described by Blomqvist et al. (1989) . Sadee et al. (1982) have shown that >90% of label in brain can be accounted for by the parent ligand 60 min after intravenous injection of la belled diprenorphine. It is therefore assumed that only the parent ligand, and not its labelled metabolites, can cross the blood-brain barrier. Within the ROI, two com partments are distinguished: the first comprising free and nonspecifically bound ligand, which are assumed to be in rapid equilibrium with each other, and the second deriv ing from specific ligand binding sites within the region. It is assumed (initially) that specific binding sites are absent from the reference region. The validity of these assump tions and the sensitivity of the analysis to them will be examined later. Total accumulation of label in the ROI (Ctot; dpm/g) as a function of time (t; min) is then described by
and that in the reference region (crc6 dpm/g -I) by
(3)
where Cp (dpm/m\) is the concentration of parent ligand label in plasma (the plasma input function); Cr (dpm/g) is the concentration of label in the combined free plus non specifically bound pool of the ROI; Cb (dpm/g) is the concentration of label in the specifically bound pool; K I and K I * (mUg/min) are the unidirectional clearances of ligand from plasma for ROI and reference region, respec tively; k2 and k2 * (min -I) are the efflux rate constants of the combined free plus nonspecifically bound pool in ROI and reference region, respectively; k 3 (min -I) = kon ( Bmax -Cb/SA), where kon(min-I/[pmol/g]) is the apparent sec ond-order association rate constant; Bmax (pmol/g) is the maximum specific binding capacity of the ROI; and SA (dpm/pmol) is the specific activity of the labelled ligand. Thus, k, is a time-dependent pseudo-first-order for ward rate constant when nontracer doses of the labelled ligand with finite specific activity are present in the sys tem. k4(min -I ) is the first-order dissociation rate constant of the receptor-ligand complex in the specifically bound pool.
The principal advantage of this model is that it allows the removal of the plasma input function term in the dif ferential equations (see below) and hence avoids the need to separate and quantify the labelled parent ligand in the plasma over the time course of the experiments, when significant peripheral metabolism is occurring. Perry et al. (1980) report up to 50% of label in metabolites in plasma 60 min after intravenous injection of labelled di prenorphine in rats, although at this time >90% of the label in brain tissue was accounted for by the parent ligand (Sadee et aI., 1982) . 
dCrer(t)ldt
Crertt)· k2* Cp(t) = K\* + K\* (5) Blomqvist et al. (1989) suggest supplementary measures of K I * and k2 * as a means of deriving the unknown Cp(t).
A simpler implementation of the reference tissue tech nique may however be applied with the additional as sumption that (6) i.e., that the ratio of influx to efflux rate constants (but not their absolute values) is the same in the ROI as in the reference region (see Discussion). Substitution of Eq. 6 into Eq. 5 with rearrangement gives where Rinflux is the influx ratio K 1/ K 1 *, which expression may in turn be substituted into Eq. 2. Thus, if the time course of label in a reference region is known, then that in the ROI may be described by five parameters: Rinflux' k2, kon, Bmax, and k4•
Fitting of data
The total data set for each region consisted of the time courses of label in tissue in the tracer alone and pulse chase protocols, plus label in tissue 30 min after intrave nous administration of tracer over a range of specific ac tivities, as described above. This total data set was used to obtain simultaneous estimates of the five model param eters (Rinflux, k2, kon, Bmax, and k4) on the basis of a nonlinear least -mean-squares fit of the model to data from each region, using the tracer alone time course of label in the cerebellum as the reference function in each case. It was assumed that the same reference function applied for all protocols and that there was no specific binding in cerebellum. (The sensitivity of the analysis to specific binding in the reference region will be considered in the next section.) Furthermore, the same set of five parame ters was assumed to apply for all protocols. This allows for data from all three protocols to contribute simulta neously to the estimates of the parameters. Any given set of parameter estimates was compared with data from the three protocols on the basis of the above basic model as follows:
The time course of label for tracer alone in cerebellum was first fitted to an arbitrary expression involving a sum of exponential terms that gave a good description of its shape (see Results). This expression and its derivative were then used in Eq. 7 and substituted into Eq. 2. Equa tions 2 and 3 are the two differential equations comprising the model. These equations were integrated numerically using a fourth-order Runge-Kutta scheme with the five parameters as variables (unless otherwise specified). For the varying specific activity protocol, the equation set was as given above. When comparing fits with data from the tracer alone protocol, Cb/SA was set to zero during integration so that k 3 = kon • Bmax. This was also done during comparison with data from the pulse chase proto col. In addition, the delivery of the displacing dose was modelled by including a delay from the time of injection of the pulse chase after which k, was set to zero (see below). In this way a residual sum ' of squares for the total regional data set was obtained for any given set of param eters. Iterative minimisation of the residual sum of squares was obtained by varying the parameter set using the Simplex method (NeIder and Mead, 1965) or a deriv ative-free nonlinear regression technique (Ralston, \983) . The inclusion of a delay in the model for the pulse chase protocol is an approximation to the time-dependent pro cess of saturation of specific binding sites. In supplemen tary work the effect of delays between 0 and 6 min on the residual sum of squares was investigated. In all regions, a minimum residual was obtained with delays between 2.5 and 3.5 min. The delay was therefore fixed at 3 min for all regions in all the fits presented in this article. The dose of cold diprenorphine used (470 pmol/g body wt) was suffi cient to cause maximal displacement of the label (see Fig. 5 ).
Correction for specific binding in the reference region
The compartmental model described above involves the assumption of negligible specific binding in the refer ence region. The sensitivity of the analysis to this as sumption was examined as follows:
When specific reference binding occurs and the la belled ligand is present in trace amounts, then where C/ is the concentration of the combined free plus nonspecifically bound tracer in the reference region and k3 * and k4 are turnover rate constants of specifically bound tracer in the reference region. Equations 8 and 9 may be solved to give Cb *(t) = k3 *Crer<t) @ exp[ -(k3 * + k4 *)tl (1 0) where "@" denotes convolution. The time course of the total tracer in the reference tissue is given by Equations 8-11, together with the assumption ex pressed in Eq. 6, may then be algebraically rearranged to give an expression analogous to Eq. 7, in which the un known plasma input function term for the ROI may be replaced by a function of the observed time course of tracer in the reference region:
Equation 12 reduces to Eq. 7 when k/ = o.
A full sensitivity analysis would require an investiga tion of the behaviour of the model and the five derived ROI parameters over a range of fixed values for both reference tissue rate constants k3 * and k4 *. To simplify this, we may take advantage of the observation (see Re sults) that the rate constants ko n and k4 show insignificant interregional variation, and therefore assume that the spe cific binding characteristics in the reference region are the same, except for total capacity, as those in the ROI. Thus, if, under tracer conditions,
and (14) where the asterisk denotes the reference region and kon and k4 refer to the ROI as above, then the equation set is simplified and again involves the five variables Rinflux, k2, kon, k4, and Bmax for the ROI, together with one fixed parameter, Bmax *, summarising the specific binding ca pacity of the reference tissue. Sensitivity analyses were therefore carried out with the constraints given in Eq. 13 and 14 over a range of fixed values for Bmax *. Table 1 .
RESULTS
Binding parameters in vitro
There was significant regional variation in Bmax, with the highest value (43 pmol/g wet wt tissue) in thalamus and with a small but significant saturable component (1. 3 pmol/g wet wt tissue) in cerebel lum. There was no significant regional variation in Kd (overall mean, 0. 198 nM) or in Kns (overall mean, 2.74 ml/g wet wt tissue). Sadee et al. (1982) have previously reported values in whole-brain homoge nates for Kd of 0. 13-0. 16 nM and for Bmax of 30 pmol/g.
Transport and binding parameters in vivo
The time course of total label in the reference region, cerebellum, after injection of tracer alone is shown in Fig. 3 . Following pulse chase administra tion of unlabelled diprenorphine, there was a small but significant displacement of label from cere bel- Values are means ± SD of parameters obtained from individual fits to four binding isotherms, measured at 37'C, pH 7.4, as described in Meth ods.
lum. The corresponding data sets for the thalamus are illustrated in Figs. 4 and 5. Figure 4 shows the retention of tracer and its marked displacement by pulse chase. Figure 5 shows the titration of label in the tissue at 30 min as a function of the coinjected dose of cold diprenorphine. There were no discern ible differences in the time profiles of total 3H counts in plasma between the three studies (data not shown).
Total data sets for the three experimental proto cols were fitted simultaneously to the compartmen tal model described in Methods. It was assumed initially that the reference region contained no spe cific binding sites. Thus, the reference input func tion was as shown in Fig. 3, Table 2 . discrete brain regions. The fits to the data for thal amus are shown in Figs. 4 and 5. Similar fits were obtained for all regions dissected and parameter es timates are summarised in Table 2 .
Regional estimates of Bmax obtained on the basis of this model in vivo (Table 2) varied over a wide range and may be compared with those obtained from the equilibrium binding study in vitro de scribed above (Table 1 ). In general, estimates of Bmax obtained in vivo were higher than those ob tained in vitro, and a bias was apparent in the rela tionship with the in vivo/in vitro ratio increasing with increasing specific regional binding capacity.
Estimates of both the second-order apparent as sociation rate constant, kon' and the first-order dis sociation rate constant, k4' showed no significant interregional variation, with overall mean values of Table 2 . Estimates (± SEM) were derived from compartmental analysis (see Fig. 1 ) assuming negligible specific binding in the reference region, cerebellum. CBF values were taken from Hargreaves et al. (1986) with haematocrit of 40% (CBF cerebellum, 0.80 ml/min/g). 0.0196 min -] pmol/g and 0.119 min -] , respectively ( Table 2 ). The relationship between these parame ters in vivo and the equilibrium half-saturation con stant, Kd, as measured in vitro will be considered in Discussion. The regional variation in both Rinflux and k2 most probably reflects relative differences in blood flow between regions. Independent estimates of regional CBF, taken from Hargreaves et al. (1986) , are also shown in Table 2 . There was signif icant interregional correlation of both Rinflux (r = 0.83, p < 0.05) and k2 (r = 0.84, p < 0.05) with CBF.
Correction for specific binding in the reference region Evidence in vitro (Table 1 ) and in vivo (Fig. 3) indicated a small but significant specific binding component in cerebellum. It was therefore of inter est to examine the sensitivity of the present analysis to this factor and, if necessary, to apply a suitable correction to the regional transport and binding pa rameters for diprenorphine. For given values of specific binding in the reference region (Bmax * ), the total data sets for the ROIs were reanalysed as de scribed in Methods. Since there was a tendency for estimates of B m ax obtained in vivo to be higher than those obtained in vitro, the in vivo ROI data were reanalysed with values for Bmax * equal to, and dou ble, the in vitro value of 1.3 pmol/g ( Table l ). There were no significant changes in goodness of fit of the model to the data in either case.
The resulting estimates of the binding parameters kon' B m ax, and k4 are given in Table 3 . These results show that failure to take into account specific bind ing in the reference region, if present, would lead to an underestimation of Bmax in the ROI, and that this underestimation is approximately constant over the range of specific binding capacities throughout the regions (�7 and 15 pmol/g in the two cases consid ered).
For kon, the effect was negligible in the high bind ing thalamus, but more marked as specific binding decreased. The mean ± SD regional values for kon J Cereb Blood Flow Metab. Vol. 11. No. 1. 1991 were 0.0196 ± 0.0044, 0.0176 ± 0.0032, and 0.0162 ± 0.0027 min -] pmol/g for Bmax * values of 0, 1.3, and 2.6 pmol/g, respectively. For k4' the effect was again approximately constant across regions, with mean ± SD values of 0.119 ± 0.019, 0.100 ± 0.015, and 0.090 ± 0.013 min -\ for Bmax * values of 0, 1.3, and 2.6, respectively.
As noted above, a bias was apparent in the rela tionship between in vivo/in vitro Bmax ratios when no correction for specific binding in the reference tissue was made. The relationship between Bmax values obtained in vitro and those obtained in vivo, after correction for specific binding in the reference region of 1.3 pmol/g, is illustrated in Fig. 6 . Regres- Estimates were derived from compartmental analysis of data in vivo (see Fig. 1 ) assuming specific binding in the reference region, cerebellum, of Bmax *. The standard errors of the esti mates are all close to the equivalent data in Table 2 . sion of in vivo estimates on in vitro estimates showed a highly significant correlation (r = 0.969, p < 0.(01), with the regression intercept passing close to the ori gin; i.e., the apparent bias has disappeared.
Omission of varying specific activity protocol in the rat
The total data from the rat were obtained from a combination of three protocols. The third protocol, namely, varying the specific activity of the injected labelled diprenorphine, serves to distinguish the kon and Bmax components of the forward rate constant [kon (Bmax -Cb/SA); see Kinetic Analyses] and hence the apparent in vivo equilibrium dissociation constant, Kd (see Discussion). In the absence of these data, when only tracer alone and pulse chase data are available, only the product kon x Bmax may be obtained, with the number of variable parame ters in the fit being reduced to four. Since our cur rent studies in humans involve only tracer alone and pulse chase protocols, it was of interest to reexam ine the data from the rat in vivo, omitting data from the third protocol. This also excludes the applica tion of the correction for specific binding in the ref erence region. The regional estimates of binding po tential so obtained are summarised in Table 4 , where they are compared with those calculated from the analysis of the complete data set with a correction for specific binding in the reference re gion of 1.3 pmol/g wet wt. Omission of the varying specific activity data led to lower estimates of kon . Bmax of between 6 and 14%.
We were unable to obtain satisfactory fits for analysis of tracer alone data. Analysis of the second protocol alone (i.e., pulse chase) gave unacceptably large errors in the parameter estimates.
DISCUSSION
This work in the rat was carried out as part of a validation study, with a view to the application of The trace alone and pulse chase data sets were fitted in terms of four parameters including the composite rate constant kon • Bm•x as described in Results. The corresponding estimates when all available data are taken into account were derived from the values given in Table 3 with a correction for specific binding in the reference region of 1.3 pmol/g wet wt. Data are means ± SEM.
compartmental analyses to dynamic PET data ob tainable in humans (Jones et aI., 1988) . The satura ble uptake of diprenorphine, its marked displace ment by pulse chase in the rat in vivo, and the re lationship of these phenomena to receptor binding in vitro have previously been described by Perry et al. (1980) and SaMe et al. (1982) . Emphasis here has been placed on experimental protocols that are more directly comparable with those feasible in PET, i.e., those that involve intravenous adminis tration of the label and the examination of the up take and binding over relatively short times, when it is important to distinguish between tracer delivery to the tissue and binding in the tissue. The compart mental model is based on the use of a reference tissue to avoid the metabolite correction necessary when a plasma time-activity curve is used as the input function. We have therefore analysed the data regionally and made direct comparisons with esti mates of binding parameters obtained from in vitro studies.
The use of full time-activity curves in dynamic studies represents the most efficient use of data available from PET, but the estimates so obtained, compared with equilibrium studies, are more sensi tive to the simplifying assumptions on which the model is based (Huang et aI., 1986) . The present reference tissue model does not assume that the rate of specific binding is small relative to the trans port rates across the blood-brain barrier and fur thermore can allow for, and hence examine the sen sitivity to, assumptions regarding the degree of spe cific binding in the reference region. It is, however, assumed that equilibrium between free and nonspe cifically bound ligand is sufficiently rapid to allow them to be treated as a single compmtment. Identity of transport rates in the ROIs and in the reference region is not required, although it is assumed that the ratio of influx and efflux rate constants is the same in all regions. This assumption leads to a ma jor simplification of the equations relating the be haviour of the tracer in the reference region to that in the ROI (see Eq. 7), giving rise to the parameter Rinflux' Whilst this assumption has not been exper imentally validated, it is justifiable since both KI and k2 are dependent on regional blood flow and on the blood-brain barrier permeability-surface area product. Interregional differences in either or both of these parameters might therefore be expected to affect both KI and k2 and maintain the ratio. The observed correlation of influx relative to the refer ence (Rinflux) and k2 with independent measures of blood flow lends support to this assumption.
Estimates of the regional maximum specific bind ing capacities in the rat in vivo correlated well with those obtained under equilibrium conditions in vitro, but estimates in vivo were higher than those in vitro and a bias was apparent. Loss of binding sites may have occurred during the preparation of the tissue homogenates in vitro. A decrease in the number of diprenorphine binding sites on increasing dilution of untreated brain homogenates was re ported by Sadee et al. (1982) , although this was ap parent at much greater dilutions than used here.
A further consideration is that the naloxone sensitive binding sites as determined in vitro may not be fully representative of the total saturable di prenorphine binding sites in the tissue, the latter being defined in vivo by a diprenorphine pulse chase and by various specific activities of diprenor phine. However, the simultaneous fitting procedure applied to the in vitro data takes into account both the slope of the isotherm in the presence of nalox one and the limiting slope of the isotherm in the absence of naloxone, which were virtually identical (see, e.g., Fig. 2) , which argues against this consid eration. The mean regional value for k4 in the rat in vivo was 0.10 min -I, which corresponds to a half-life of 6.9 min. This value compares with dissociation rate constants determined in vitro at 37°C by Sadee et al. (1982) who report 20--30 min in buffer alone and 10 min in the presence of 100 mM NaCI.
The rate constant kon' as estimated from compart mental analysis of data in vivo, is referred to as the "apparent" second-order association rate constant for two reasons: First, it is applied to the compart ment representing both free and nonspecifically bound ligand in rapid equilibrium, rather than to the free ligand alone; and second, the true physical vol ume (mllg tissue) occupied by the free ligand is not defined. These considerations are necessary if the fractional rate constants and label per gram of tis-J Cereb Blood Flow Metab. Vol. 11, No.1, 1991 sue, in which the present model is formulated, are to be related to the effective concentration of free ligand at the binding site (Mintun et aI. , 1984) . If the free fraction of the combined pool is denoted f2 and physical volume V2 (see notation of Mintun et aI., 1984) , then the association rate constant applicable to the concentration of free ligand in this volume (ka; min -1/nM) is given by
Thus, given estimates of f2 and V2, the association and dissociation rate constants in vivo may then be related to a corresponding equilibrium dissociation constant, Kd (nM):
The present results give a mean value for the non specific binding constant in tissue homogenates in vitro (Kns) of 2. 74 mllg wet wt tissue. If a similar partition between free and nonspecifically bound ligand pertains in vivo, then an estimate of the free fraction of the combined free plus nonspecifically bound compartment (Fig. 2 ) may be made. Under the simplest of assumptions, in which the free ligand is contained in the tissue water space (0.76 mllg; Mintun et aI. , 1984) , the corresponding value off2 is 0.76/(2.74 + 0.76) = 0.22. The correspond ing estimate of Kd in vivo, based on the mean values for kon and k4 (see Results), is 1. 59 nM. This esti mated value for Kd in vivo is thus about an order of magnitude greater than that obtained under equilib rium binding conditions in vitro (0.198 nM).
Several factors may contribute to this discrep ancy. Amongst those arising from a necessarily sim plified compartmental analysis is the possibility of local diffusional gradients around the specific bind ing sites. This phenomenon, which would be man ifest in dynamic studies as opposed to studies made under equilibrium conditions, could arise if reasso ciation of the ligand with the binding site was oc curring rapidly relative to its rate of mixing with the total free pool. Perry et al. (1980) raised this possi bility specifically in the case of diprenorphine bind ing in vivo and included an extra compartment to distinguish reassociating ligand from the bulk of the free pool. We have investigated this possibility in a preliminary analysis with data in rats collected un der the tracer alone protocol (Jones et aI., 1989) and with the present data from the three protocols. Briefly, an additional pool, was added to the com partmental model communicating with the free plus nonspecifically bound compartment with rate con stants kin and kout (see notation of Perry et aI., 1980) and communicating with the bound pool with rate constants k3 and k4• The total data sets were then refitted for the original five variables together with kin as a sixth variable and with kout set at fixed val ues. The inclusion of this local rapidly reassociating fraction of free ligand in the compartmental model aff ected principally the estimate of k O fi" The remain ing variables were little changed and there were no significant differences in the residual sum of squares (F test). Thus, for example, in thalamus, where the ratio k4/kon was 7.2 pmollg in the absence of a local pool (data from Table 2 ), inclusion of the extra compartment with kout set at 10 min -1 (Perry et aI., 1980) led to a value for k4/kon of 0.74. Al though this value is an order of magnitude less, it cannot necessarily be interpreted as indicating the in vivo Kd to be correspondingly less since account should also be taken of the physical volume occu pied by the reassociating fraction. The fitted value for kin this particular case was 1.05 min -1 . The small apparent distribution volume of the reassoci ating fraction relative to the remaining free pool (km/ kout = 0.105) is consistent with a correspondingly smaller physical volume. Thus, the change in the apparent second-order rate constant kon (applicable to concentrations expressed per gram of tissue) could equally well reflect a smaller physical distri bution volume (and hence higher concentration in nanomolar terms) of the reassociating pool. Al though diffusional gradients may contribute to the discrepancy between the in vitro and in vivo Kd reported here, these figures based on compartmen tal approximations are not a sufficient explanation. Zeeberg et al. (1988) have also considered the ef fects of diffusional gradients and heterogeneity of receptor distribution and conclude that such effects may contribute to in vivo/in vitro discrepancies. The suitability of diffusion models for the analysis of ligand binding in vivo is currently being investi gated.
In conclusion, the present study establishes ex perimentally a kinetic model using a reference tis sue, which adequately describes the behaviour of diprenorphine in vivo. Restriction of the data to tracer alone and displacement protocols gave esti mates of the forward rate constant that correlate with interregional variation of Bmax, indicating that kinetic analysis of dynamic tracer studies can be used to give an adequate description of regional binding capacity. The results obtained in rat would indicate that with use of this combination of two protocols (i.e., tracer alone and pulse chase), as is feasible within the constraints of PET, the model could be applied to describe satisfactorily the re gional distribution of opioid receptor sites in hu mans.
